Correlation Between Weiss Korea and SkinBioTherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Weiss Korea and SkinBioTherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Weiss Korea and SkinBioTherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Weiss Korea Opportunity and SkinBioTherapeutics PLC, you can compare the effects of market volatilities on Weiss Korea and SkinBioTherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Weiss Korea with a short position of SkinBioTherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Weiss Korea and SkinBioTherapeutics.

Diversification Opportunities for Weiss Korea and SkinBioTherapeutics

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Weiss and SkinBioTherapeutics is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Weiss Korea Opportunity and SkinBioTherapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SkinBioTherapeutics PLC and Weiss Korea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Weiss Korea Opportunity are associated (or correlated) with SkinBioTherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SkinBioTherapeutics PLC has no effect on the direction of Weiss Korea i.e., Weiss Korea and SkinBioTherapeutics go up and down completely randomly.

Pair Corralation between Weiss Korea and SkinBioTherapeutics

Assuming the 90 days trading horizon Weiss Korea Opportunity is expected to under-perform the SkinBioTherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Weiss Korea Opportunity is 2.09 times less risky than SkinBioTherapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The SkinBioTherapeutics PLC is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  1,363  in SkinBioTherapeutics PLC on September 14, 2024 and sell it today you would earn a total of  362.00  from holding SkinBioTherapeutics PLC or generate 26.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Weiss Korea Opportunity  vs.  SkinBioTherapeutics PLC

 Performance 
       Timeline  
Weiss Korea Opportunity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Weiss Korea Opportunity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
SkinBioTherapeutics PLC 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SkinBioTherapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SkinBioTherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Weiss Korea and SkinBioTherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Weiss Korea and SkinBioTherapeutics

The main advantage of trading using opposite Weiss Korea and SkinBioTherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Weiss Korea position performs unexpectedly, SkinBioTherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SkinBioTherapeutics will offset losses from the drop in SkinBioTherapeutics' long position.
The idea behind Weiss Korea Opportunity and SkinBioTherapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format